NCT02732275 2025-02-07DS-3201b in Participants With LymphomasDaiichi SankyoPhase 1 Active not recruiting100 enrolled
NCT04014374 2024-07-24Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With MogamulizumabKyowa Kirin Co., Ltd.Recruiting150 enrolled
NCT02689453 2022-04-29Subcutaneous Recombinant Human IL-15 (s.c. rhIL-15) and Alemtuzumab for People With Refractory or Relapsed Chronic and Acute Adult T-cell Leukemia (ATL)National Institutes of Health Clinical Center (CC)Phase 1 Completed11 enrolled 16 charts
NCT02580552 2020-11-23Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLLmiRagen Therapeutics, Inc.Phase 1 Completed66 enrolled
NCT00699296 2012-11-27Study of Oral LBH589 in Patients With Cutaneous T-cell Lymphoma and Adult T-cell Leukemia/LymphomaNovartisPhase 2 Terminated4 enrolled